002166 莱茵生物
已收盘 08-07 15:00:00
资讯
新帖
简况
股市必读：莱茵生物（002166）7月31日董秘有最新回复
证券之星 · 08-03
股市必读：莱茵生物（002166）7月31日董秘有最新回复
莱茵生物：与海内外众多品牌客户建立稳定合作
证券之星 · 07-23
莱茵生物：与海内外众多品牌客户建立稳定合作
莱茵生物：公司自主推出莱茵零界精酿白啤
证券之星 · 07-16
莱茵生物：公司自主推出莱茵零界精酿白啤
莱茵生物：公司客户遍布全球60多个国家和地区
证券之星 · 07-16
莱茵生物：公司客户遍布全球60多个国家和地区
股市必读：莱茵生物（002166）预计2026年1-6月每股收益盈利:0.07元至0.08元
证券之星 · 07-15
股市必读：莱茵生物（002166）预计2026年1-6月每股收益盈利:0.07元至0.08元
莱茵生物：预计2026年1-6月扣非后净利润盈利4043.21万元至5054.01万元
证券之星 · 07-14
莱茵生物：预计2026年1-6月扣非后净利润盈利4043.21万元至5054.01万元
莱茵生物：公司总部所在地桂林厂区未受到本轮广西强降雨的影响
证券之星 · 07-14
莱茵生物：公司总部所在地桂林厂区未受到本轮广西强降雨的影响
莱茵生物：桂林厂区未受强降雨影响
证券之星 · 07-10
莱茵生物：桂林厂区未受强降雨影响
莱茵生物：坚持深耕天然大健康产业
证券之星 · 06-25
莱茵生物：坚持深耕天然大健康产业
莱茵生物：终止控制权变更系交易双方综合考虑多种市场因素慎重做出的决定
证券之星 · 06-25
莱茵生物：终止控制权变更系交易双方综合考虑多种市场因素慎重做出的决定
莱茵生物最新公告：控股股东终止协议转让及控制权变更事项
证券之星 · 06-22
莱茵生物最新公告：控股股东终止协议转让及控制权变更事项
股市必读：莱茵生物（002166）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：莱茵生物（002166）6月1日董秘有最新回复
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，5月22日股价上涨1.16%
证券之星 · 05-22
莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，5月22日股价上涨1.16%
股市必读：莱茵生物（002166）5月19日董秘有最新回复
证券之星 · 05-20
股市必读：莱茵生物（002166）5月19日董秘有最新回复
莱茵生物：公司利川提取工厂生产运营状态正常
证券之星 · 05-19
莱茵生物：公司利川提取工厂生产运营状态正常
莱茵生物：公司与德福资本合作事宜正在积极推进中
证券之星 · 05-19
莱茵生物：公司与德福资本合作事宜正在积极推进中
莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中
证券之星 · 05-18
莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中
莱茵生物：公司依规严格履行信息披露义务
证券之星 · 05-18
莱茵生物：公司依规严格履行信息披露义务
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
证券之星 · 05-18
莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中
莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排
证券之星 · 05-18
莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排
公司概况
公司名称：
桂林莱茵生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2007-09-13
主营业务：
桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物、瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。
发行价格：
9.89
{"stockData":{"symbol":"002166","market":"SZ","secType":"STK","nameCN":"莱茵生物","latestPrice":6.77,"timestamp":1786086201000,"preClose":6.68,"halted":0,"volume":12730106,"delay":0,"changeRate":0.0135,"floatShares":739000000,"shares":742000000,"eps":0.2088,"marketStatus":"已收盘","change":0.09,"latestTime":"08-07 15:00:00","open":6.65,"high":6.77,"low":6.6,"amount":85129600,"amplitude":0.0254,"askPrice":6.77,"askSize":1043,"bidPrice":6.76,"bidSize":323,"shortable":0,"etf":0,"ttmEps":0.2088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786325400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.68,"symbolType":"stock","openAndCloseTimeList":[[1786066200000,1786073400000],[1786078800000,1786086000000]],"highLimit":7.35,"lowLimit":6.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":741609425,"isCdr":false,"pbRate":1.55,"roa":"--","peRate":32.423372,"roe":"1.34%","epsLYR":0.1945,"committee":0.074209,"marketValue":5021000000,"turnoverRate":0.0172,"status":0,"floatMarketCap":5000000000},"requestUrl":"/m/hq/s/002166/wiki","defaultTab":"wiki","newsList":[{"id":"2656343312","title":"股市必读：莱茵生物（002166）7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343312","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343312?lang=zh_cn&edition=full","pubTime":"2026-08-03 02:35","pubTimestamp":1785695713,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，莱茵生物报收于6.65元，上涨2.15%，换手率1.65%，成交量12.19万手，成交额8032.81万元。董秘最新回复投资者： 莱茵生物深耕天然健康成分与合成生物学，十五五疾病规划中关于“慢性病防治”与“全民健康”的导向，将为贵公司带来业务机遇？但政策导向不代表业绩必然兑现，业务发展还受市场竞争、客户拓展等多重因素影响。当日关注点交易信息汇总：7月31日主力资金净流入264.96万元，占总成交额3.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001026.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","BK0174","002166","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713119","title":"莱茵生物：与海内外众多品牌客户建立稳定合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713119","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713119?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:44","pubTimestamp":1784778296,"startTime":"0","endTime":"0","summary":"贵司作为天然甜味剂提取的龙头企业，贵司的产品质量受到众多国内外客户的高度评价和认可，这是可喜可贺的事情。贵司产品通过国内外众多头部品牌企业的率先采用，带动了其他品牌客户的需求，这种销售策略也值得赞扬。近年来公司持续发力开拓下游应用市场，与海内外众多品牌客户建立稳定合作，覆盖食品、饮料、化妆品、医药等赛道，同时在调味品、宠物及动物等新领域的拓展也收获阶段性成效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300020096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","BK0046","BK0028","002166","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651418375","title":"莱茵生物：公司自主推出莱茵零界精酿白啤","url":"https://stock-news.laohu8.com/highlight/detail?id=2651418375","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651418375?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:33","pubTimestamp":1784172791,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司植物提取的甜味，能酿进啤酒的清爽？莱茵生物用罗汉果酒哪里有售？莱茵生物回复：您好！公司罗汉果提取物、甜叶菊提取物均属于天然甜味剂，可应用于酒类饮品，替代蔗糖，赋予产品自然甜味，亦可增添风味。公司自主推出莱茵零界精酿白啤，产品做到零蔗糖、零脂肪，配方添加罗汉果提取物，兼顾消费者畅饮体验与健康需求。欢迎投资者在微信搜索“Ulife优植生活商城”小程序了解相关产品。温馨提示，饮酒要适量，谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600015083.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0168","BK0028","002166","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651183294","title":"莱茵生物：公司客户遍布全球60多个国家和地区","url":"https://stock-news.laohu8.com/highlight/detail?id=2651183294","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651183294?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:33","pubTimestamp":1784172788,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司已与全球多少个国家和地区的约几家食品、饮料、保健品及医药原料贸易商开展业务往来？莱茵生物回复：您好，公司客户遍布全球60多个国家和地区，涵盖全球知名食品、饮料、化妆品生产商等。谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600015078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0174","BK0028","BK0168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748604","title":"股市必读：莱茵生物（002166）预计2026年1-6月每股收益盈利:0.07元至0.08元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748604","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651748604?lang=zh_cn&edition=full","pubTime":"2026-07-15 04:02","pubTimestamp":1784059335,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，莱茵生物报收于6.46元，上涨2.54%，换手率1.27%，成交量9.37万手，成交额5982.78万元。业绩披露要点业绩预告预计2026年1-6月每股收益盈利0.07元至0.08元；扣非后净利润盈利4043.21万元至5054.01万元；归属净利润盈利4954.3万元至6097.6万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500005658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0174","BK0028","BK0168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651101153","title":"莱茵生物：预计2026年1-6月扣非后净利润盈利4043.21万元至5054.01万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651101153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651101153?lang=zh_cn&edition=full","pubTime":"2026-07-14 22:02","pubTimestamp":1784037777,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物发布业绩预告，预计2026年1-6月扣非后净利润盈利4043.21万元至5054.01万元。桂林莱茵生物科技股份有限公司董事会二〇二六年七月十五日莱茵生物2026年一季报显示，一季度公司主营收入4.47亿元，同比上升0.58%；归母净利润4251.65万元，同比上升38.06%；扣非净利润4032.82万元，同比上升11.6%；负债率36.17%，投资收益5.27万元，财务费用1367.88万元，毛利率23.72%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400049052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651912038","title":"莱茵生物：公司总部所在地桂林厂区未受到本轮广西强降雨的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2651912038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651912038?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:07","pubTimestamp":1784012835,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：近期广西连续特大暴雨对公司有影响么莱茵生物回复：尊敬的投资者，您好！公司总部所在地桂林厂区未受到本轮广西强降雨的影响，截至目前公司生产经营一切正常，感谢您对公司的关心。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400022732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0168","BK0174","BK0028","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650095209","title":"莱茵生物：桂林厂区未受强降雨影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2650095209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650095209?lang=zh_cn&edition=full","pubTime":"2026-07-10 11:33","pubTimestamp":1783654435,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问：广西最近暴雨对公司生产经营是否有影响？莱茵生物回复：尊敬的投资者，您好！公司总部所在地桂林厂区未受到本轮广西强降雨的影响，截至目前公司生产经营一切正常，感谢您对公司的关心。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000016295.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0174","BK0239","BK0046","BK0028","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646080874","title":"莱茵生物：坚持深耕天然大健康产业","url":"https://stock-news.laohu8.com/highlight/detail?id=2646080874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646080874?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:48","pubTimestamp":1782391708,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500041573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0168","BK0174","BK0046","BK0239","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646016847","title":"莱茵生物：终止控制权变更系交易双方综合考虑多种市场因素慎重做出的决定","url":"https://stock-news.laohu8.com/highlight/detail?id=2646016847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646016847?lang=zh_cn&edition=full","pubTime":"2026-06-25 09:01","pubTimestamp":1782349266,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)06月24日在投资者关系平台上答复投资者关心的问题。投资者提问：秦本军：由于市场环境变化原因，经双方协商一致，同意终止本次公司控制权变更事项。请问详细说明市场环境有哪些变化原因？莱茵生物回复：您好，终止控制权变更系交易双方综合考虑多种市场因素慎重做出的决定，包括一二级市场环境变化等，谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500007452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0239","BK0174","BK0046","BK0028","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645724024","title":"莱茵生物最新公告：控股股东终止协议转让及控制权变更事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2645724024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645724024?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:11","pubTimestamp":1782130268,"startTime":"0","endTime":"0","summary":"莱茵生物(002166.SZ)公告称，公司控股股东秦本军与广州德福营养签署终止协议，因市场环境变化，双方协商一致终止本次控制权变更事项。原协议约定秦本军向广州德福营养转让6000万股(占总股本8.09%)并放弃部分表决权，但股份尚未过户，公司控股股东及实控人仍为秦本军，本次终止不会对公司生产经营产生重大不利影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200034797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","002166","BK0028","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640669729","title":"股市必读：莱茵生物（002166）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640669729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640669729?lang=zh_cn&edition=full","pubTime":"2026-06-02 01:39","pubTimestamp":1780335550,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，莱茵生物报收于8.27元，下跌0.24%，换手率1.17%，成交量8.65万手，成交额7162.0万元。董秘最新回复投资者： 董秘你好：请问1，德福控股莱茵生物交易和金康普注入莱茵是一揽子交易吗？3，莱茵生物拥有行业内许多专利，包括即将获批的RM2，而德福旗下产业与莱茵有很多重合，如何保证这些专利不会流失？交易信息汇总资金流向6月1日主力资金净流出918.77万元；游资资金净流入680.41万元；散户资金净流入238.36万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200001389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002166","BK0174","BK0028","BK0168","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637731859","title":"莱茵生物（002166）披露控制权变更及发行股份购买资产事项进展公告，5月22日股价上涨1.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637731859","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637731859?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:41","pubTimestamp":1779442913,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，莱茵生物报收于8.69元，较前一交易日上涨1.16%，最新总市值为64.45亿元。近日，莱茵生物发布《关于公司控制权变更、发行股份购买资产并募集配套资金暨关联交易事项的进展公告》。公告显示，桂林莱茵生物科技股份有限公司于2025年12月22日签署协议，原控股股东秦本军向广州德福营养转让公司8.09%股份，并放弃25.50%股份表决权。截至公告披露日，股份转让诚意金已支付30%，审计、评估、尽职调查等工作正有序推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200033957.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0174","002166","BK0046","BK0168","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636611368","title":"股市必读：莱茵生物（002166）5月19日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636611368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636611368?lang=zh_cn&edition=full","pubTime":"2026-05-20 03:57","pubTimestamp":1779220628,"startTime":"0","endTime":"0","summary":"截至2026年5月19日收盘，莱茵生物报收于8.82元，上涨1.15%，换手率1.06%，成交量7.85万手，成交额6897.9万元。董秘最新回复投资者： 德福资本合作进度是否在等某种条件，比如RM2获批作为条件董秘： 您好，公司与德福资本合作事宜正在积极推进中，不存在您提及的这种情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000004972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0168","002166","BK0028","BK0239","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636383341","title":"莱茵生物：公司利川提取工厂生产运营状态正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2636383341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636383341?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:27","pubTimestamp":1779175630,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：利川项目还有生产吗，主要产品是什么，多大产量莱茵生物回复：您好，公司利川提取工厂生产运营状态正常，主营产品为茶提取物，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900021987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002166","BK0046","BK0168","BK0028","BK0174","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636783311","title":"莱茵生物：公司与德福资本合作事宜正在积极推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636783311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636783311?lang=zh_cn&edition=full","pubTime":"2026-05-19 15:27","pubTimestamp":1779175629,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月19日在投资者关系平台上答复投资者关心的问题。投资者提问：德福资本合作进度是否在等某种条件，比如RM2获批作为条件莱茵生物回复：您好，公司与德福资本合作事宜正在积极推进中，不存在您提及的这种情形。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051900021985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0174","BK0239","BK0046","002166","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636904694","title":"莱茵生物：甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636904694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636904694?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:42","pubTimestamp":1779075725,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月18日在投资者关系平台上答复投资者关心的问题。公司甜菊糖苷RM2国内食品添加剂新品种认证申报目前处于审评中，最终能否获批以及拿证周期尚存在不确定性，敬请投资者注意投资风险。目前，公司甜菊糖苷RM2已取得FDA GRAS认证，具备海外合规销售资质，相关产能设施也已布局完备，后续公司将稳步推进海外市场拓展，逐步释放合成生物车间产能，推动业务稳健发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800013142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","159151","BK0046","BK0239","BK0174","002166","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046589","title":"莱茵生物：公司依规严格履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046589","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636046589?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:36","pubTimestamp":1779075376,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物05月18日在投资者关系平台上答复投资者关心的问题。在控制权变更、发行股份购买资产及募集配套资金项目上，公司依规严格履行信息披露义务，不存在应披露而未披露的事项，敬请各位投资者理性投资，注意投资风险，谢谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0174","BK0028","BK0168","BK0046","BK0239","002166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636463300","title":"莱茵生物：公司股份协议转让及发行股份购买资产等交易，处于积极推进当中","url":"https://stock-news.laohu8.com/highlight/detail?id=2636463300","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636463300?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:33","pubTimestamp":1779075219,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：公司控制权变更和金康普股权收购事项已过去5个月，目前审批进展如何？是否遇到障碍？何时能完成交割？如果延期，原因是什么？莱茵生物回复：您好，公司股份协议转让及发行股份购买资产等交易，处于积极推进当中，项目最终能否按照预期实现落地，存在一定的不确定性，请投资者注意投资风险。公司将严格按照相关法律法规要求及时披露项目进展情况，敬请投资者及时关注公司公告。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0168","002166","BK0028","BK0239","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636046354","title":"莱茵生物：现阶段公司各工厂生产进度、运营节奏符合公司规划安排","url":"https://stock-news.laohu8.com/highlight/detail?id=2636046354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2636046354?lang=zh_cn&edition=full","pubTime":"2026-05-18 11:33","pubTimestamp":1779075218,"startTime":"0","endTime":"0","summary":"证券之星消息，莱茵生物(002166)05月18日在投资者关系平台上答复投资者关心的问题。投资者提问：甜叶菊新工厂投产已一段时间，现实际产能利用率多少？是否达到预期？美国工厂运营状况和盈利情况如何？美国CBD产业政策日益友好，公司业务拓展增量多少？谢谢莱茵生物回复：感谢您的关注。现阶段公司各工厂生产进度、运营节奏符合公司规划安排，整体业务经营平稳有序。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800012587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0174","BK0046","002166","BK0168"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786103474634,"stockEarnings":[{"period":"1week","weight":0.0261},{"period":"1month","weight":0.0603},{"period":"3month","weight":-0.2612},{"period":"6month","weight":-0.2708},{"period":"1year","weight":-0.1952},{"period":"ytd","weight":-0.201}],"compareEarnings":[{"period":"1week","weight":0.0251},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.0669},{"period":"6month","weight":-0.0406},{"period":"1year","weight":0.0733},{"period":"ytd","weight":-0.0173}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"桂林莱茵生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"39042人(较上一季度减少4.05%)","perCapita":"18917股","listingDate":"2007-09-13","address":"广西壮族自治区桂林市临桂区人民南路19号","registeredCapital":"74160万元","survey":" 桂林莱茵生物科技股份有限公司的主营业务是植物功能性成分的研发与生产。公司的主要产品是罗汉果提取物、甜叶菊提取物、茶叶提取物及其他植物提取物、瑞鲍迪苷RM2及甜菊糖苷RM系列产品、左旋β-半乳葡聚糖等。","listedPrice":9.89},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莱茵生物,002166,莱茵生物股票,莱茵生物股票老虎,莱茵生物股票老虎国际,莱茵生物行情,莱茵生物股票行情,莱茵生物股价,莱茵生物股市,莱茵生物股票价格,莱茵生物股票交易,莱茵生物股票购买,莱茵生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莱茵生物(002166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莱茵生物(002166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}